阿昔洛韦的皮肤不良反应：病例报告
Cutaneous adverse reactions to acyclovir: case reports.
作者信息
Robinson G E, Weber J, Griffiths C, Underhill G S, Jeffries D J, Goldmeir D
出版信息
Genitourin Med. 1985 Feb;61(1):62-3. doi: 10.1136/sti.61.1.62.
Abstract
Intravenous, oral, and topical formulations of acyclovir have been successful in treating genital herpes. We report on two patients who developed skin reactions while taking acyclovir, which resolved when treatment was stopped.
摘要
阿昔洛韦的静脉、口服和外用制剂在治疗生殖器疱疹方面已取得成功。我们报告了两名在服用阿昔洛韦时出现皮肤反应的患者，这些反应在停药后得到缓解。
相似文献
1
Cutaneous adverse reactions to acyclovir: case reports.
Genitourin Med. 1985 Feb;61(1):62-3. doi: 10.1136/sti.61.1.62.
2
Oral acyclovir for treatment and suppression of genital herpes simplex virus infection. A review.
JAMA. 1986 Apr 4;255(13):1747-9.
3
Genital herpes.
Sex Transm Infect. 2017 Sep;93(6):444. doi: 10.1136/sextrans-2016-053005. Epub 2017 Jun 15.
4
Efficacy of combined treatment with oral and topical acyclovir in first episode genital herpes.
Genitourin Med. 1986 Jun;62(3):186-8. doi: 10.1136/sti.62.3.186.
5
Double-blind placebo-controlled trial of oral acyclovir in first-episode genital herpes simplex virus infection.
JAMA. 1984 Sep 7;252(9):1147-51.
6
A comparison of topical application of penciclovir 1% cream with acyclovir 3% cream for treatment of genital herpes: a randomized, double-blind, multicentre trial.
Int J STD AIDS. 2000 Sep;11(9):568-73. doi: 10.1258/0956462001916533.
7
Oral form of acyclovir approved.
FDA Drug Bull. 1985 Apr;15(1):3-4.
8
Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial.
JAMA. 1984 Apr 27;251(16):2103-7.
9
Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir.
N Engl J Med. 1984 Jun 14;310(24):1545-50. doi: 10.1056/NEJM198406143102401.
10
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects.
N Engl J Med. 1983 Apr 21;308(16):916-21. doi: 10.1056/NEJM198304213081602.
引用本文的文献
1
Delayed allergy to acyclovir revealed by lymphocyte proliferation test.
Postepy Dermatol Alergol. 2018 Oct;35(5):527-529. doi: 10.5114/ada.2018.77244. Epub 2018 Jul 19.
2
Adverse drug reactions triggered by the common HLA-B*57:01 variant: virtual screening of DrugBank using 3D molecular docking.
J Cheminform. 2018 Jan 30;10(1):3. doi: 10.1186/s13321-018-0257-z.
3
Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity.
PLoS One. 2015 May 29;10(5):e0124878. doi: 10.1371/journal.pone.0124878. eCollection 2015.
4
Localized bullous eruptions away from infusion site due to intravenous acyclovir administration in a child.
Indian J Pharmacol. 2012 Jan;44(1):126-8. doi: 10.4103/0253-7613.91885.
5
Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.
Drugs. 1989 Mar;37(3):233-309. doi: 10.2165/00003495-198937030-00002.
本文引用的文献
1
Preliminary studies of acyclovir in chronic hepatitis B.
Am J Med. 1982 Jul 20;73(1A):267-70. doi: 10.1016/0002-9343(82)90103-6.
2
Acyclovir halts progression of herpes zoster in immunocompromised patients.
N Engl J Med. 1983 Jun 16;308(24):1448-53. doi: 10.1056/NEJM198306163082404.
3
A trial of topical acyclovir in genital herpes simplex virus infections.
N Engl J Med. 1982 Jun 3;306(22):1313-9. doi: 10.1056/NEJM198206033062201.
4
Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes.
Lancet. 1982 Sep 11;2(8298):571-3. doi: 10.1016/s0140-6736(82)90658-4.
5
Intravenous acyclovir treatment for primary genital herpes.
Lancet. 1982 Mar 27;1(8274):697-700. doi: 10.1016/s0140-6736(82)92618-6.
Zotero 插件